Amid the recent rise in Covid-19 cases in India, driven by the subvariant of Omicron XBB.1.16, there has been an increase in risk of conjunctivitis among children aged below one-year, according to a study, not yet peer-reviewed.

The study, led by Vipin M. Vashishtha, member of WHO`s Vaccine Safety Net, is based on 25 children seen in OPD of a paediatric hospital in Uttar Pradesh between April 4-16.